. Author manuscript; available in PMC: 2017 Aug 25.

Published in final edited form as: Acad Radiol. 2016 Jul 18;23(9):1073–1082. doi: 10.1016/j.acra.2016.04.004

TABLE 3.

Comparison Diffusion-weighted Imaging Values for Reduced Diffusion Group

	T2 Area	T2	T2	T2R	CE Area	CE	CE	CE
	(cm²)	rADC_min	rADC_mean	rADC_max	(cm²)	rADC_min	rADC_mean	rADC_max
PreTx	17.3 (13.0)	0.95 (0.15)	1.71 (0.41)	2.06 (0.35)	3.25 (3.43)	1.01 (0.18)	1.46 (0.23)	1.81 (0.35)
PostTx	20.5 (9.91)	0.58 (0.13)	1.210.13)	1.88 (0.59)	4.49 (8.69)	0.69 (0.17)	1.05 (0.13)	1.35 (0.59)
P value	0.44	0.01	0.01	0.30	0.60	0.01	0.01	0.01

CE, contrast enhancing region of interest; Max, maximum value; Mean, average value; Mean (standard deviation), T2, T2 FLAIR hyperintensity region of interest; Min, minimum value; PostTx, following bevacizumab administration; PreTx, before bevacizumab administration.